Low grade glioma
MONDO:0021637A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.
Also known as: benign glioma, glioma, benign, low grade glioma, low-grade glioma
1702 clinical trials for this condition and its sub-types, 71 tagged with Low grade glioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Low grade glioma
-
Grade II glioma 28 trials · 179 incl. sub-types
5 sub-types
- Ependymoma 87 trials · 89 incl. sub-types Sub-types →
- Oligodendroglioma 62 trials Sub-types →
- Diffuse astrocytoma 25 trials · 28 incl. sub-types Sub-types →
- Oligoastrocytoma 6 trials · 15 incl. sub-types Sub-types →
- Chordoid glioma of the third ventricle 1 trial
-
Schwannoma 9 trials · 42 incl. sub-types
10 sub-types
- Acoustic neuroma 35 trials
- Schwannomatosis 3 trials Sub-types →
- Cellular schwannoma 0 trials
- Melanotic neurilemmoma 0 trials Sub-types →
- Microcystic/reticular schwannoma 0 trials
- Peripheral nerve schwannoma 0 trials Sub-types →
- Plexiform schwannoma 0 trials
- Schwannoma of twelfth cranial nerve 0 trials
- Sympathetic neurilemmoma 0 trials
- Trigeminal schwannoma 0 trials
-
Low grade astrocytic tumor 1 trial · 41 incl. sub-types
1 sub-type
- Low-grade astrocytoma 5 trials · 41 incl. sub-types Sub-types →
-
Childhood low-grade glioma 7 trials
-
Angiocentric glioma 1 trial
Most studied deeper sub-types
-
Could dropping one chemo drug improve life for young brain tumor patients?
Disease control CompletedThis phase III trial compares two chemotherapy approaches for children and young adults with previously untreated low grade glioma, a type of brain or spinal cord tumor. One group receives the standard combination of carboplatin and vincristine, while the other receives carboplat…
Phase 3 • Sponsor: Alicia Lenzen • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a dementia drug shield kids' brains from radiation damage?
Disease control CompletedThis pilot study tested whether memantine, a drug used for dementia in adults, could help prevent memory and thinking problems in children receiving brain radiation for tumors like glioma or craniopharyngioma. 41 children aged 6-21 took either memantine or a placebo during radiat…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for kids with Hard-to-Treat cancers: targeted drug shows promise
Disease control CompletedThis study tested a drug called tazemetostat in 20 children whose cancers had come back or weren't responding to treatment. The children had specific gene changes (EZH2, SMARCB1, or SMARCA4) in their tumors. The goal was to see if the drug could shrink or slow the growth of these…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental drug AB-218 tested in brain tumor patients
Disease control CompletedThis study tested a drug called AB-218 (safusidenib) in 14 adults with a specific type of slow-growing brain tumor (IDH1 mutated low grade glioma) who were already scheduled for surgery. The goal was to see if it's possible to measure how much drug gets into the tumor and to chec…
Early phase 1 • Sponsor: Melbourne Health • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug combo targets brain tumor fuel in early trial
Disease control CompletedThis early-phase study tested two experimental drugs, AG-120 and AG-881, in 49 adults with a recurrent, slow-growing brain tumor (low grade glioma) that has a specific IDH1 gene mutation. The goal was to see if these drugs could lower a substance called 2-HG in the tumor tissue b…
Phase 1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for kids with tough brain tumors: experimental drug shows promise in early trial
Disease control CompletedThis early-phase study tested a drug called Tovorafenib in 44 children with low-grade gliomas (a type of brain tumor) that had come back or continued growing despite other treatments. The main goal was to find the safest dose and check for side effects. The drug works by blocking…
Phase 1 • Sponsor: Karen D. Wright, MD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for kids with brain tumors: targeted pill shows promise
Disease control CompletedThis study tested a drug called MEK162 in 105 children with low-grade gliomas or other tumors that have a specific overactive growth signal. The goal was to find the best dose, check for side effects, and see if the drug could shrink tumors. Children took the drug by mouth twice …
Phase 1/2 • Sponsor: Children's Hospital Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New dye could sharpen PET scans for recurrent brain cancer
Diagnosis CompletedThis study tested whether a special dye called fluoroethyltyrosine (FET) can improve PET scans for detecting brain tumors that have come back. 143 people with suspected recurrent brain tumors received an injection of FET before their PET scan. The goal was to see if FET-PET could…
Phase 2 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Light probe could help surgeons spot brain tumors Mid-Operation
Diagnosis CompletedThis early study tested a special light probe that helps surgeons see brain tumor tissue during an operation. Eleven adults with suspected brain tumors took part. The probe uses a drug that makes tumor cells glow, and the goal was to see if the device could accurately tell tumor …
Phase 1 • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Cancer patients report more memory lapses, study finds
Knowledge-focused CompletedThis study looked at memory complaints in 426 people, including those with brain tumors, breast cancer, and healthy volunteers. Participants filled out questionnaires about their memory, mood, and fatigue. The goal was to understand how cancer and its treatments might affect ever…
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
New scanner could spot brain tumor types without a needle
Knowledge-focused CompletedThis study tested a new type of MRI-like scan called Field Cycling Imaging (FCI) on 9 people who had surgery for low-grade gliomas. The goal was to see if FCI can tell apart different subtypes of these slow-growing brain tumors without needing another surgery or biopsy. Each part…
Sponsor: NHS Grampian • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Brain tumor study reveals hidden toll of chemo on daily life
Knowledge-focused CompletedThis study followed 26 adults with low-grade glioma who were receiving chemotherapy (temozolomide) for the first time after surgery. Researchers measured how the treatment affected patients' quality of life, thinking skills, and emotional well-being over one year. The goal was to…
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New brain scan could sharpen surgery for glioma patients
Knowledge-focused CompletedThis pilot study tested whether a special PET scan using 18F-FDOPA can help doctors better plan surgery and radiation for people with newly diagnosed brain tumors (gliomas). Twenty-four adults took part at Mayo Clinic. The goal was to see if the scan provides useful information b…
Early phase 1 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:06 UTC